ABSTRACTS OF THE 21st ANNUAL MEETING OF THE ITALIAN ...
ABSTRACTS OF THE 21st ANNUAL MEETING OF THE ITALIAN ...
ABSTRACTS OF THE 21st ANNUAL MEETING OF THE ITALIAN ...
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
androgen receptor (AR). Despite anorchid serum androgen<br />
levels, nearly all patients develop castration-resistant disease.<br />
We hypothesized, on the basis of previous experience (1), that<br />
ongoing steroidogenesis within prostate tumors and the<br />
maintenance of intratumoral androgens may contribute to<br />
castration-resistant growth. Recently, Montgomery et al. (2)<br />
demonstrated that median testosterone levels within metastatic<br />
tumors from castrated men are approximately three-fold higher<br />
than the levels within primary prostate tumors from untreated<br />
eugonadal men. The study further showed statistically<br />
significant (p50%<br />
(median 87.1%, range 50.2% to 94.4%). PSA normalization (